Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Kramnik

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
FEBS Letters|June 3, 2020
SON DNA-binding protein mediates macrophage autophagy and responses to intracellular infectionDavid J Gregory, Glen M DeLoid, Sharon L Salmon, et al.
Msphere|April 17, 2020
The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of ProtectionSherry L Kurtz, Amy P Rossi, Gillian L Beamer, et al.
Journal of Visualized Experiments : Jove|August 25, 2025
Iterative Bleaching Extends Multiplicity with Use of Staining Automation for Core FacilitiesAnna E Tseng, Aoife O'Connell, Aaron Benhamou, et al.
Plos Pathogens|September 7, 2013
The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanismXianbao He, Robert Berland, Samrawit Mekasha, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Elimination of senescent cells with senolytic host-directed therapy reduces tuberculosis progression in miceSomnath Shee, Yazmin B Martinez-Martinez, Benjamin Koleske, et al.
Scientific Reports|April 19, 2016
Fine-tuning of macrophage activation using synthetic rocaglate derivativesBidisha Bhattacharya, Sujoy Chatterjee, William G Devine, et al.
STAR Protocols|February 21, 2025
Protocol for 3D multiplexed fluorescent imaging of pulmonary TB lesions using Opal-TSA dyes for signal amplificationSuruchi Lata, Shivraj M Yabaji, Aoife K O'Connell, et al.
Nature Microbiology|April 18, 2020
Publisher Correction: Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1RaDaisy X Ji, Livia H Yamashiro, Katherine J Chen, et al.
Nature Microbiology|October 16, 2019
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1RaDaisy X Ji, Livia H Yamashiro, Katherine J Chen, et al.
Nature Communications|May 7, 2026
Elimination of senescent cells with senolytic drugs as adjunctive host-directed therapy reduces tuberculosis progression in miceSomnath Shee, Yazmin B Martinez-Martinez, Benjamin Koleske, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
FEBS Letters|June 3, 2020
SON DNA-binding protein mediates macrophage autophagy and responses to intracellular infectionDavid J Gregory, Glen M DeLoid, Sharon L Salmon, et al.
Msphere|April 17, 2020
The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of ProtectionSherry L Kurtz, Amy P Rossi, Gillian L Beamer, et al.
Journal of Visualized Experiments : Jove|August 25, 2025
Iterative Bleaching Extends Multiplicity with Use of Staining Automation for Core FacilitiesAnna E Tseng, Aoife O'Connell, Aaron Benhamou, et al.
Plos Pathogens|September 7, 2013
The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanismXianbao He, Robert Berland, Samrawit Mekasha, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Elimination of senescent cells with senolytic host-directed therapy reduces tuberculosis progression in miceSomnath Shee, Yazmin B Martinez-Martinez, Benjamin Koleske, et al.
Scientific Reports|April 19, 2016
Fine-tuning of macrophage activation using synthetic rocaglate derivativesBidisha Bhattacharya, Sujoy Chatterjee, William G Devine, et al.
STAR Protocols|February 21, 2025
Protocol for 3D multiplexed fluorescent imaging of pulmonary TB lesions using Opal-TSA dyes for signal amplificationSuruchi Lata, Shivraj M Yabaji, Aoife K O'Connell, et al.
Nature Microbiology|April 18, 2020
Publisher Correction: Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1RaDaisy X Ji, Livia H Yamashiro, Katherine J Chen, et al.
Nature Microbiology|October 16, 2019
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1RaDaisy X Ji, Livia H Yamashiro, Katherine J Chen, et al.
Nature Communications|May 7, 2026
Elimination of senescent cells with senolytic drugs as adjunctive host-directed therapy reduces tuberculosis progression in miceSomnath Shee, Yazmin B Martinez-Martinez, Benjamin Koleske, et al.
Pageof 6